Evaluation of clinical efficacy of undenatured type II collagen supplementation compared to cimicoxib and their association in dogs affected by natural occurring osteoarthritis

Stabile, Marzia; Lacitignola, Luca; Samarelli, Rossella; Fiorentino, Marco; Crovace, Antonio; Staffieri, Francesco

doi:10.1016/j.rvsc.2022.06.030

Cited by 8 publications

(8 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clinical improvements recorded in this study were based on the veterinarian and owner evaluation. Although the scoring systems used in this study has been validated and already used in previous clinical studies 17,[56][57][58][59] , the use of an objective tool, as gait analysis mat, for kinematic and kinetic evaluation, might have been desirable for the aim of this study, but unfortunately not applicable at time of the data collection.…”

Section: Discussionmentioning

confidence: 99%

1H-NMR metabolomic profile of healthy and osteoarthritic canine synovial fluid before and after UC-II supplementation

Stabile

Girelli

Lacitignola

et al. 2022

Sci Rep

Self Cite

View full text Add to dashboard Cite

The aim of the study was to compare the metabolomic synovial fluid (SF) profile of dogs affected by spontaneous osteoarthritis (OA) and supplemented with undenatured type II collagen (UC-II), with that of healthy control dogs. Client-owned dogs were enrolled in the study and randomized in two different groups, based on the presence/absence of OA (OA group and OA-free group). All dogs were clinically evaluated and underwent SF sampling for 1H-Nuclear Magnetic Resonance spectroscopy (1H-NMR) analysis at time of presentation. All dogs included in OA group were supplemented with UC-II orally administered for 30 days. After this period, they were reassessed (OA-T30). The differences in the 1H-NMR metabolic SFs profiles between groups (OA-free, OA-T0 and OA-T30) were studied. The multivariate statistical analysis performed on SFs under different conditions (OA-T0 vs OA-T30 SFs; OA-T0 vs OA-free SFs and OA-T30 vs OA-free SFs) gave models with excellent goodness of fit and predictive parameters, revealed by a marked separation between groups. β-Hydroxybutyrate was identified as a characteristic compound of osteoarthritic joints, showing the important role of fat metabolism during OA. The absence of β-hydroxybutyrate after UC-II supplementation suggests the supplement’s effectiveness in rebalancing the metabolism inside the joint. The unexpectedly high level of lactate in the OA-free group suggests that lactate could not be considered a good marker for OA. These results prove that 1H-NMR-based metabolomic analysis is a valid tool to study and monitor OA and that UC-II improves clinical symptoms and the SF metabolic profile in OA dogs.

show abstract

Section: Discussionmentioning

confidence: 99%

1H-NMR metabolomic profile of healthy and osteoarthritic canine synovial fluid before and after UC-II supplementation

Stabile

Girelli

Lacitignola

et al. 2022

Sci Rep

Self Cite

View full text Add to dashboard Cite

show abstract

“…Its uniqueness lies in its high collagen concentration, resulting in an administered dose that is up to 18 times higher than those investigated in prior studies [15][16][17]45]. The influence of T2NDC on joint function and pain levels has been examined and validated in several studies in dogs [15][16][17]20,46]. Currently, it is hypothesized that oral tolerization is induced through a mechanism known as bystander suppression, which necessitates only a small amount of antigen.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of the Effects of an Undenatured Collagen Type-2-Based Nutraceutical (ARTHROSHINE® HA²) on Recovery Time after TPLO in Dogs: A Prospective, Randomized Study with Objective Gait Analysis as the Primary Outcome Measure

Assies,

Berger,

Stegen

et al. 2024

Animals

View full text Add to dashboard Cite

This randomized, prospective clinical trial investigates the impact of a novel undenatured collagen type 2 (T2NDC)-based nutraceutical, ARTHROSHINE® HA² (AS), on postoperative rehabilitation following Tibial Plateau Leveling Osteotomy (TPLO) in 50 dogs with unilateral cranial cruciate ligament rupture (CCLR). The patients were randomly allocated to either group A, receiving AS once daily for 24 weeks post-TPLO surgery, or group B, without any supplementation. Frequency matching was applied to enhance group comparability. Assessment of outcomes included computerized gait analysis and a validated owner questionnaire. AS supplementation was well received, without any reported side effect. Consistently, patients in group A exhibited significantly higher peak vertical force values during all follow-up assessments. By the 12-week mark, gait analysis indicated a return to a physiological gait pattern in group A, while group B achieved this normalization only by the 24-week point. The administration of AS post-TPLO surgery demonstrates promise in enhancing limb function, leading to faster restoration of a physiological gait pattern. The inclusion of AS, a T2NDC-based nutraceutical, in the post-TPLO rehabilitation protocol may contribute to improved limb function and an expedited recovery, potentially facilitating a quicker return to normalcy. It is noteworthy that subjective owner perceptions did not differ between the two groups.

show abstract

“…The combination of UC-II ® with HCA and CM seemed to show improved benefits through the reduction in overall pain, pain upon limb manipulation and exercise-associated lameness [56]. The management of OA with UC-II ® was analysed in two studies comparing the use of Robenacoxib and Cimicoxib, and there were no significant differences [60,65]. The pain assessment questionnaires completed by the owners and veterinarians showed favourable results after the use UC-II ® [60,[65][66][67].…”

Section: Undenatured Type II Collagenmentioning

confidence: 99%

“…The management of OA with UC-II ® was analysed in two studies comparing the use of Robenacoxib and Cimicoxib, and there were no significant differences [60,65]. The pain assessment questionnaires completed by the owners and veterinarians showed favourable results after the use UC-II ® [60,[65][66][67]. The results obtained using quantitative methods for the gait analysis showed an improvement in step force [57,58,66].…”

Section: Undenatured Type II Collagenmentioning

confidence: 99%

Management of Osteoarthritis and Joint Support Using Feed Supplements: A Scoping Review of Undenatured Type II Collagen and Boswellia serrata

Zapata

Fernández-Parra

2023

Animals

View full text Add to dashboard Cite

In the multimodal management of osteoarthritis (OA) in recent decades, the use of feed supplements to maintain joint cartilage has been advocated. The aim of this scoping review is to present the results found in the veterinary literature on the use of undenatured type II collagen and Boswellia serrata in dogs, specifically its use in dogs with clinical signs of OA, healthy dogs after intense exercise or dogs with diseases that predispose the individual to OA. For this purpose, a literature review was carried out using the electronic databases PubMed, Web of Science and Google Scholar, from which a total of 26 records were included in this review: fourteen evaluating undenatured type II collagen, ten evaluating Boswellia serrata and two evaluating the combination of undenatured type II collagen and Boswellia serrata. The review of the records showed that undenatured type II collagen decreases the clinical signs associated with OA, improving the general clinical state with a reduction in the degree of lameness and increase in physical activity or mobility. Evaluating the response to supplementation with Boswellia serrata alone is complicated due to the limited publication of studies and variations in the purity and compositions of the products used, but in general terms, its combination with other feed supplements produces benefits by relieving pain and reducing the clinical signs of OA in dogs. The combination of both in the same product provides results similar to those obtained in undenatured type II collagen studies. In conclusion, undenatured type II collagen and Boswellia serrata are considered a valid option for the multimodal approach to the management of OA and for improving activity during intense exercise, but more studies are needed to conclude whether or not it prevents OA in dogs.

show abstract

Evaluation of clinical efficacy of undenatured type II collagen supplementation compared to cimicoxib and their association in dogs affected by natural occurring osteoarthritis

Cited by 8 publications

References 46 publications

1H-NMR metabolomic profile of healthy and osteoarthritic canine synovial fluid before and after UC-II supplementation

1H-NMR metabolomic profile of healthy and osteoarthritic canine synovial fluid before and after UC-II supplementation

Evaluation of the Effects of an Undenatured Collagen Type-2-Based Nutraceutical (ARTHROSHINE® HA²) on Recovery Time after TPLO in Dogs: A Prospective, Randomized Study with Objective Gait Analysis as the Primary Outcome Measure

Management of Osteoarthritis and Joint Support Using Feed Supplements: A Scoping Review of Undenatured Type II Collagen and Boswellia serrata

Contact Info

Product

Resources

About